Decoy Therapeutics Inc. (DCOY) Operating cash flow 2016–2025
Decoy Therapeutics Inc. (DCOY) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.8MFY2025 · since FY2016: -$32.1M → -$4.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.8M | -6.7% |
| FY2024 | -$4.5M | +64.8% |
| FY2023 | -$12.8M | +27.0% |
| FY2022 | -$17.6M | -72.5% |
| FY2021 | -$10.2M | +1.1% |
| FY2020 | -$10.3M | +11.0% |
| FY2019 | -$11.6M | -377.2% |
| FY2018 | $4.2M | +115.1% |
| FY2017 | -$27.7M | +13.5% |
| FY2016 | -$32.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice